Abstract:Carbon monoxide (CO) has been shown to induce several cardiovascular abnormalities, as well as necrosis, apoptosis and oxidative stress in the brain. Magnesium sulfate (MS) has been shown to have beneficial activities against hypoxia in the brain. In the present study, the possible protective effects of MS against CO-induced cerebral ischemia were investigated. For this purpose, 25 male Wistar rats were exposed to 3,000 ppm CO for 1 h. The animals were divided into 5 groups (n=5 in each group) as follows: The … Show more
“…The BAX/Bcl-2 ratio is considered a measure of cell susceptibility to apoptosis [28] as well as proapoptotic index [29]. This ratio was found to be significantly decreased in the current study as reported earlier and may be due to the increased apoptosis via increasing proapoptotic Bax and decreasing antiapoptotic Bcl-2 expression in an animal model [30,31].…”
“…The BAX/Bcl-2 ratio is considered a measure of cell susceptibility to apoptosis [28] as well as proapoptotic index [29]. This ratio was found to be significantly decreased in the current study as reported earlier and may be due to the increased apoptosis via increasing proapoptotic Bax and decreasing antiapoptotic Bcl-2 expression in an animal model [30,31].…”
“…COP leads to inhibition of O 2 transport and development of tissue hypoxia, which in turn causes cell apoptosis 49 . Due to the nonrenewability of neurons, some scholars believe that apoptosis is an important pathogenesis of brain injury caused by COP 23,50 . Jurič et al found that carbon monoxide decreased the activity of astrocyte cells, increased the reactive oxygen species, and reduced the mitochondrial membrane potential and intracellular ATP level.…”
The pathogenesis of brain injury caused by carbon monoxide poisoning (COP) is very complex, and there is no exact and reliable treatment in clinic. In the present study, we screened the therapeutic target and related signal pathway of Salvia Miltiorrhiza for acute COP brain injury, and clarified the pharmacological mechanism of multicomponent, multitarget, and multisignal pathway in Salvia Miltiorrhiza by network pharmacology. To further verify the therapeutic effect of Salvia Miltiorrhiza on acute brain injury based on the results of network analysis, a total of 216 male healthy Sprague Dawley rats were collected in the present study and randomly assigned to a normal control group, a COP group and a Tanshinone IIA sulfonate treatment group (72 rats in each group). The rat model of acute severe COP was established by the secondary inhalation in a hyperbaric oxygen chamber. We found that Salvia Miltiorrhiza had multiple active components, and played a role in treating acute brain injury induced by COP through multiple targets and multiple pathways, among them, MAPK/ERK1/2 signaling pathway was one of the most important. COP can start apoptosis process, activate the MAPK/ERK1/2 signaling pathway, and promote the expression of VEGF‐A protein and the formation of brain edema. Tanshinone IIA can effectively inhibit apoptosis, up‐regulate the expressions of VEGF‐A, P‐MEK1/2 and P‐ERK1/2 proteins, thereby protect endothelial cells, promote angiogenesis and microcirculation, and finally alleviate brain edema.
“…Worldwide, vascular dementia is the second most common form of dementia accompanied by obvious cognitive dysfunction after Alzheimer's disease ( 29 ), and MID is a common type of vascular dementia. Currently, no licensed drugs are available for the treatment of vascular dementia ( 30 ), and the reported therapeutic strategies for the disease primarily focus on inhibiting oxidative stress, apoptosis and inflammation ( 31 , 32 ). Multiple and cortical microinfarctions are closely related to dementia and cognition ( 33 ), which is associated with their direct influence on the production of ATP in the brain ( 7 ).…”
Multi infarct dementia (MID) is a form of dementia that is preventable and treatable. However, at present, the drugs used in MID treatment were developed for Alzheimer's disease. While only a limited range of drugs is available, the incidence of MID is increasing year on year. The present study aimed to investigate the effect and underlying mechanisms of a combination of ginsenosides and astragalosides (CGA) on cognitive decline in rats with MID. A rat model of MID was established using micro-thromboembolism, and the behavioral changes in the rats were evaluated using the Morris water maze and open field tests at 60 days post-CGA intervention. The pathological morphology of the hippocampal CA1 area was observed using hematoxylin and eosin staining. The contents of ATP, ADP and AMP were determined using high-performance liquid chromatography. Mitochondrial swelling and changes in the membrane potential in the hippocampus were detected using flow cytometry, and the changes in insulin, glutamate and γ-aminobutyric acid (GABA) content were detected using ELISA. Additionally, the expression of PI3K and AKT proteins was detected using western blot analysis. In a rat model of MID, CGA shortened the escape latency, increased the frequency of platform crossing, improved the disordered vertebral cell arrangement and reduced the cell number in the hippocampal CA1 area. CGA also reduced the degree of mitochondrial swelling, increased the mitochondrial membrane potential, and elevated the energy load and ATP content in the brain of rats with MID. Furthermore, CGA increased the insulin content and upregulated the expression of PI3K and AKT in the brain of rats with MID. In addition, in the rat model of MID, CGA also enhanced the movement time and the frequency of standing, and decreased the concentration of glutamate and GABA in the brain tissue. Amelioration of the cognitive decline in rats with MID by CGA was associated with its regulatory effect on the PI3K/AKT signaling pathway and neurotransmitter systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.